Clinical Trials

Clicking a link below will scroll the
page down to the relevant section

Lung Cancer
Mesothelioma

Lung Cancer

top

A Phase I Study of PDX (Pralatrexate) Supplemented with Vitamin B12 and Folic Acid in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
Azzoli, Christopher, MD

[Protocol 04-105]
A Phase I/II Study of Cisplatin, Etoposide, and Sunitinib for Untreated Advanced Small Cell Lung Cancer
Krug, Lee, MD

[Protocol 07-106]
A Phase I/II Study of Obatoclax Mesylate (GX15-070MS) Plus Topotecan in Patients with Relapsed Small Cell Lung Carcinoma
Krug, Lee, MD

[Protocol 07-082]
A Phase I/II Trial of Fixed Doses of Daily Gefitinib with Escalating Doses of Daily RAD001 in Advanced Non-Small Cell Lung Cancer
Miller, Vincent, MD

[Protocol 04-033]
A Phase II Study of BIBW 2992 in Non-Small Cell Lung Cancer Patients with EGFR-Activating Mutations
Miller, Vincent, MD

[Protocol 07-180]
A Phase II Study of Erlotinib (Tarceva^®) With or Without Carboplatin/Paclitaxel in Patients with Untreated Lung Adenocarcinoma Who Never Smoked or Were Former Light Smokers
Miller, Vincent, MD

[Protocol 05-127]
A Phase II Study of Erlotinib and Chemotherapy for Operable Stage IB-IIIA Non-Small Cell Lung Cancer Patients Who Are Nonsmokers or Light Smokers
Rizvi, Naiyer, MD

[Protocol 07-103]
A Phase II Study of Salirasib for the Treatment of Advanced Non-Small Cell Lung Cancer
Riely, Gregory, MD, PhD

[Protocol 07-110]
A Phase II Study of Sunitinib (Sutent^®) in Patients with Non-Small Cell Lung Cancer that Has Spread to the Brain
Abrey, Lauren, MD

[Protocol 07-010]
A Phase II Study of XL647 in Subjects with Non Small-Cell Lung Cancer
Rizvi, Naiyer, MD

[Protocol 06-099]
A Phase II Trial of Dasatinib in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
Miller, Vincent, MD

[Protocol 06-143]
A Phase II Trial to Correlate Response to Gefitinib with Mutations in the EGFR Gene in Patients with Non-Small Cell Lung Cancer
Rizvi, Naiyer, MD

[Protocol 04-071]
A Phase IIIb Trial Comparing Bevacizumab Therapy with/without Erlotinib After Completion of Chemotherapy with Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer
Miller, Vincent, MD

[Protocol 06-098]
A Pilot Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects with Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer
Azzoli, Christopher, MD

[Protocol 06-057]
A Pilot Trial Assessing the Safety and Immunogenicity of the GI-4000 Vaccine as Consolidation Therapy after Curative Treatment for Stage I-III Non-Small Cell Lung Cancers with K-ras Mutations
Azzoli, Christopher, MD

[Protocol 07-149]
A Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients with Thoracic and Myeloid Neoplasms
Krug, Lee, MD

[Protocol 06-085]
Health Communication in Families
Hay, Jennifer, PhD

[Protocol 03-088]
Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging
Kraus, Dennis, MD

[Protocol 05-036]
Lung Cancer Informational Study (LCIS)
Tyson, Leslie, MSN, NP

[Protocol 06-141]
Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer
Azzoli, Christopher, MD

[Protocol 02-111]
Methylated Genes in Blood as Biomarkers for Early-Stage Non-Small Cell Lung Cancer
Rusch, Valerie, MD

[Protocol 02-112]
Multimodality Treatment for Patients with Resectable Non-Small Cell Lung Cancer (BEACON Study: BEvacizumab And Chemotherapy for Operable NSCLC)
Rizvi, Naiyer, MD

[Protocol 05-052]
Physical Activity and Inactivity in Lung Cancer Survivors
Ostroff, Jamie, PhD

[Protocol 05-094]
Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Lobectomy versus Thoracotomy and Lobectomy
Park, Bernard, MD

[Protocol 05-006]
Quality of Life in Lung Cancer Survivors
Ostroff, Jamie, PhD

[Protocol 05-057]
Screening for Depression in Lung Cancer Patients
Passik, Steven, PhD

[Protocol 06-038]
The Use of Breathing Synchronized PET/CT Imaging in the Detection and Quantification of FDG Uptake in Lung Nodules
Schoder, Heiko, MD

[Protocol 04-025]

Mesothelioma

top

A Phase III Trial of Oral Suberoylanilide Hydroxamic Acid (L-001079038) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy
Krug, Lee, MD

[Protocol 05-095]
A Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients with Thoracic and Myeloid Neoplasms
Krug, Lee, MD

[Protocol 06-085]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org